Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses

References

• American Advertising Federation (2003) Urgent threat to DTC pharmaceutical advertising, http://www.aaf.org/government/legislative_20030624.html.
   Google Scholar
• American College of Physicians and the American Society of Internal Medicine (1998) Direct to consumer advertising for prescription drugs, http://www.acponline.org/hpp/pospaper/dtcads.htm.
   Google Scholar
• American Medical Association (2000) Council on Ethical and Judicial Affairs of the American Medical Association, Direct-to-consumer advertisements of prescription drugs. Food and Drug Law Journal, 55(1), pp. 119.124.
   Google Scholar
• Anthony, J., Hoek, J. & Holdershaw, J. (2003) Brand advertising of prescription medicines: a comparison of communication formats. Paper presented at the European Marketing Academy Conference, University of Strathclyde, UK, 22.25 May.
   Google Scholar
• Basara, L.R. (1992) Direct-to-consumer advertising: today.s issues and tomorrows outlook. Journal of Drug Issues, 22(2), pp. 317.330.
   Google Scholar
• Basara, L.R. (1996) The impact of a DTC prescription medicine advertising campaign on new prescription volume. Drug Information Journal, 30, pp. 715.729.
   Google Scholar
• Bell, R., Kravitz, R. & Wilkes, M. (1999) Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14(11), pp. 651.657.
   Google Scholar
• Blue Cross Blue Shield Association (2002) Business leaders identify healthcare cost drivers; BCBSA research highlights perception of key cost drivers, press release, 7 March 2002, Chicago, IL.
   Google Scholar
• Burton, T. (2002) Backlash rises against flashy ads for prescription pharmaceuticals. Wall Street Journal, 13 March.
   Google Scholar
• Calfee, J. (2002) Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy & Marketing, 21, pp. 174.193.
   Google Scholar
• Calfee, J. (2003) What do we know about direct-to-consumer advertising of prescription drugs? Health Affairs, W3, pp. 116.119, 26 February.
   Google Scholar
• Calfee, J. & Ringold, D. (1994) The seventy percent majority: enduring consumer beliefs about advertising. Journal of Public Policy and Marketing, 11(2), pp. 228.238.
   Google Scholar
• Codd, M. (2003) Report of a review of therapeutic advertising in Australia and New Zealand, Toogawala Consulting, http://www.tga.health.gov.au/docs/pdf/advrev.pdf.
   Google Scholar
• Coney, S. (2002) Direct to consumer advertising of prescription pharmaceuticals . a consumer perspective from New Zealand. Journal of Public Policy and Marketing, 21(2), pp. 213.223.
   Google Scholar
• Davis, J. (2001) Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs. Journal of Health Communication, 5, pp. 349.369.
   Google Scholar
• Food and Drug Administration (FDA) (1999) Guidance for industry consumer directed broadcast advertisements, http://www.fda.gov/cder/guidance/1804q&a.htm.
   Google Scholar
• Food and Drug Administration (FDA) (2001) Warning letter details, http://www.fda.gov/cder/warn.
   Google Scholar
• Food and Drug Administration (FDA) (2003) Direct-to-consumer promotion: public meeting, http://www.fda.gov/cder/ddmac/DTCmeeting2003.html.
   Google Scholar
• Food and Drug Administration (FDA) (2004) Draft guidance for industry: brief summary: disclosing risk information in consumer-directed print advertisements, 4 February 2004, http://www.fda.gov/cder/guidance/5669dft.pdf.
   Google Scholar
• Federal Trade Commission, Bureau of Economics, Bureau of Consumer Protection, and Office of Policy Planning (2001) Comments to the Office of Management and Budget on the assessment of physician and patient attitudes toward direct-to-consumer (DTC) promotion drugs, Docket No. 01N-0078, 24 September 2001.
   Google Scholar
• Government Accounting Office (2002) Prescription Drugs: FDA Oversight of Directto-Consumer Advertising has Limitations. Washington, DC: United States General Accounting Office.
   Google Scholar
• Hoek, J. (2000) Evaluation of therapeutic advertising advisory service/pre-vetting. Report prepared for Association of New Zealand Advertisers, October 2000.
   Google Scholar
• Hoek, J. & Gendall, P. (2002a) Direct to consumer advertising of prescription medicines: self-regulation or legislation? Journal of Marketing Communications, 8(2), pp. 71.85.
   Google Scholar
• Hoek, J. & Gendall, P. (2002b) DTC down under: an alternative perspective and regulatory framework. Journal of Public Policy and Marketing, 18(2), pp. 202.212.
   Google Scholar
• Hoek, J. & Gendall, P. (2003) Direct to consumer advertising of prescription medicines: a consumer survey. Department of Marketing Research Report, April 2003.
   Google Scholar
• Ives, N. (2003) FDA reviews ads for drugs. New York Times, 29 September 2003.
   Google Scholar
• King, A. (2003) Mid-winter dialogue, Christchurch Medical School. Speech presented on 7 August 2003, http://www.beehive.govt.nz/ViewDocument.cfm?DocumentID=17505.
   Google Scholar
• Kopp, S. & Bang, H.-K. (2000) Benefit and risk information in prescription drug advertising: a review of empirical studies and marketing implications. Health Management Quarterly, 17(3), pp. 39.56.
   Google Scholar
• Lexchin, J. & Mintzes, B. (2002) Direct-to-consumer advertising of prescription drugs: the evidence says no. Journal of Public Policy and Marketing, 21(2), pp. 194.202.
   Google Scholar
• Lichtenberg, F. (2002/2003) New drugs: health and economic impacts. NBER Reporter, Winter, pp. 5.8.
   Google Scholar
• Mansfield, P. (1999) Report on DTC pharmaceutical promotion for PHARMAC, http://www.healthyskepticism.org/.
   Google Scholar
• Ministry of Health (2000) Direct to consumer advertising of prescription medicines in New Zealand: a discussion paper, November 2000.
   Google Scholar
• Ministry of Health (2001) Summary of submissions on the direct to consumer advertising of prescription medicines in New Zealand: discussion paper, May 2001.
   Google Scholar
• Mintzes, B. (2001) Pills, persuasion and public health policies. Report of an expert survey on direct to consumer advertising of prescription drugs in Canada, the United States and New Zealand. Centre for Health Services and Public Policy, University of British Columbia.
   Google Scholar
• Morris, L., Brinberg, D., Klimberg, R., Rivera, C. & Millstein, L. (1986a) Consumer attitudes about advertisements of medicinal drugs. Social Science Medicine, 22(6), pp. 629.638.
   Google Scholar
• Morris, L.A., Brinberg, D., Klimberg, R., Rivera, C. & Millstein, L.G. (1986b) The attitudes of consumers toward direct advertising of prescription drugs. Public Health Reports, 101(1), pp. 82.89.
   Google Scholar
• Morris, L.A., Brinberg, D., Klimberg, R., Rivera, C. & Millstein, L.G. (1986c) Miscomprehension rates for prescription drug advertisements. Current Issues & Research in Advertising, 9(1), pp. 93.117.
   Google Scholar
• Morris, L. & Griffin, J. (1992) The evolving role of FDA in prescription drug promotion. Journal of Drug Issues, 22(2), pp. 245.256.
   Google Scholar
• Moynihan, R., Heath, I. & Henry, D. (2002) Education and debate selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal, 324, pp. 886.891.
   Google Scholar
• National Conference of State Legislatures, USA (2002) Direct-to-consumer advertising of pharmaceuticals, http://www.healthyskepticism.org/reports/2002/dtca%20020205.htm.
   Google Scholar
• National Consumers. League (2003) Survey on direct-to-consumer advertising of prescription drugs, http://www.nclnet.org/dtcsurvey.htm.
   Google Scholar
• National Health Council (2002) National Health Council statement on direct-to-consumer prescription drug advertising, http://www.nationalhealthcouncil.org/advocacy/dtc.htm.
   Google Scholar
• Peyrot, M., Alperstein, N., van Doren, D. & Poli, L. (1998) Direct to consumer advertisements can influence behaviour. Marketing Health Services, 18(2), pp. 26.32.
   Google Scholar
• PHARMAC (2000) Pharmaceutical Management Agency Ltd. PHARMAC Submission for Ministry of Health review of direct to consumer advertising. Wellington, NZ, November 2000.
   Google Scholar
• Pines, W. (1997) Three principles that govern FDA advertising and promotion regulation. Drug Information Journal, 31, pp. 137.142.
   Google Scholar
• Pines, W. (2002) The ABCs of Rx commercials on TV. WebMD Medical News, 3 December 1999, http://my.webmd.com/content/article/1728.52857.
   Google Scholar
• Pinto, M., Pinto, J. & Barber, J. (1998) The impact of pharmaceutical direct advertising: opportunities and obstructions. Health Marketing Quarterly, 15(4), pp. 89.101.
   Google Scholar
• Pratt, P. (2000) The results of a regulatory compliance survey of direct-toconsumer advertisements for medicines. Wellington: Medsafe.
   Google Scholar
• Researched Medicines Industry (2000) Direct to consumer advertising can enhance public health report, June 2000.
   Google Scholar
• Rosenthal, M., Berndt, R., Donohue, J., Frank, R. & Epstein, A. (2002) Promotion of prescription drugs to consumers. New England Journal of Medicine, 346(7), pp. 498.505.
   Google Scholar
• Roth, M. (1996) Patterns in direct to consumer prescription drug advertising and their public policy implications. Journal of Public Policy and Marketing, 15(1), pp. 63.75.
   Google Scholar
• Russell, D. (2003) Editorial. Consumer Magazine, February 2003.
   Google Scholar
• Saunders, B. (2003a) Direct to consumer advertising of prescription drugs in New Zealand: Professors. protest to government placed under the microscope. Wellington: Saunders Unsworth Limited, http://www.asa.co.nz.
   Google Scholar
• Saunders, B. (2003b) Direct to consumer advertising . where does the public interest lie? New Zealand Medical Journal, 116(1180), http://www/nzma.org.nz/journal/116-1180/557/.
   Google Scholar
• Slaughter, E. (2001.2002) 5th Annual Survey, Consumer reaction to DTC advertising of prescription medicines: DTC advertising and self-care, honoring requests for prescription medicines. Prevention Magazine Report.
   Google Scholar
• Social Audit (2000) Letter to EC consultation on advertising and electronic commerce, http://www.socialaudit.org.uk/5111-002.htm.
   Google Scholar
• Toop, L., Richards, D., Dowell, T., Tilyard, M., Fraser, T. & Arroll, B. (2003) Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit?, http://www.chmeds.ac.nz/report.pdf.
   Google Scholar
• Wiggs, G. (2003) The New Zealand experience with DTC. Paper presented at the American Enterprise Institute Seminar, Washington, DC, 29 May.
   Google Scholar
• Wilkes, M., Bell, R. & Kravitz, R. (2000) D-T-C prescription drug advertising: trends, impact and implications. Health Affairs, 19(2), pp. 110.128.
   Google Scholar
• Wolfe, S.M. (2002) Direct-to-consumer advertising . education or emotion promotion? New England Journal of Medicine, 346, pp. 524.526.
   Google Scholar